Stereotaxis (STXS) Free Cash Flow Growth (3y) (2013 - 2026)
Stereotaxis (STXS) Free Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 65.83% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 414.89% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 27.06% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 4.44% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 23.97% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -3.97% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -37.68% |
| 10 | Stereotaxis | 180.48 Mn | 165.86 Mn | 3.79 Mn | -3.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.77% |
| Dec 31, 2025 | -11.41% |
| Sep 30, 2025 | -15.37% |
| Jun 30, 2025 | -27.83% |
| Mar 31, 2025 | 18.65% |
| Dec 31, 2024 | 36.14% |
| Sep 30, 2024 | -42.26% |
| Jun 30, 2024 | -235.19% |
| Mar 31, 2024 | -90.56% |
| Dec 31, 2023 | -114.87% |
| Sep 30, 2023 | -26.47% |
| Jun 30, 2023 | -35.88% |
| Mar 31, 2023 | -13.31% |
| Dec 31, 2022 | -14.84% |
| Sep 30, 2022 | -88.03% |
| Jun 30, 2022 | -51.01% |
| Mar 31, 2022 | -23.27% |
| Dec 31, 2021 | -45.32% |
| Sep 30, 2021 | -51.08% |
| Jun 30, 2021 | -29.76% |